Methodological challenges in biomedical HIV prevention trials / Committee on the Methodological Challenges in HIV Prevention Trials, Board on Global Health ; Stephen W. Lagakos and Alicia R. Gable, editors ; Institute of Medicine of the National Academies.

Format Electronic
Publication InfoWashington, D.C. : National Academies Press,
Descriptionxi, 258 p. : ill. ; 23 cm.
Supplemental ContentFull text available from Ebook Central - Academic Complete
Subjects
AIDS (Disease)--Prevention.
HIV Infections--prevention & control.
Clinical Trials as Topic.
Program Evaluation--methods.
Anti-Infective Agents--therapeutic use.
Anti-Retroviral Agents--therapeutic use.

Other author/creatorLagakos, Stephen W.
Other author/creatorGable, Alicia.
Other author/creatorInstitute of Medicine (U.S.). Committee on the Methodological Challenges in HIV Prevention Trials.
Other author/creatorInstitute of Medicine (U.S.). Board on Global Health.
Other author/creatorNational Academies (U.S.)
Abstract "This IOM committee was formed at the request of the Bill & Melinda Gates Foundation and charged with addressing methodological challenges in late-stage nonvaccine biomedical HIV prevention trials with a specific focus on microbicide and pre-exposure prophylaxis trials."
Bibliography noteIncludes bibliographical references.
Access restrictionAvailable only to authorized users.
Other formsAlso available online.
Technical detailsMode of access: World Wide Web
Genre/formElectronic books.
LCCN 2008299718
ISBN0309114306 (pbk.)
ISBN9780309114301 (pbk.)